The US market for Hemostats and Sealants regained its pre-pandemic stride in Q321 as many procedures mostly returned to normal volumes.
As surgical procedures returned to pre-pandemic levels, the US Hemostats and Sealants market continued to grow, according to SmartTRAK Financial Dashboard. Growth was strong across all segments and all companies showed gains. However, as COVID-19 surges across the northern tier of states and new variants such as Omicron appear, some of that progress could be in jeopardy.
Among the many topics covered in detail in our comprehensive Q321 US Hemostats and Sealants Market Recap* are:
- Complete Q321 US Hemostats and Sealants Market Overview
- SmartTRAK's Expert Analysis and Insights
- All Market News including Revenues, Data, Charts and Shares
- US Hemostats and Sealants Market Continues Its Growth
- Absorbable Hemostats Grow Faster
- Sealants Come Back
- Notable Q321 Events
JNJ/Ethicon pulled ahead in the US Hemostats and Sealants market in Q321, sustaining growth as procedures recovered. Second-place Baxter saw a smaller gain while Becton Dickinson* (BD) remained in third place.
Read the entire Q321 US Hemostats and Sealants Market Recap, including our expert analysis, news, data, charts, company revenues and shares*
*The entire unedited article and these links can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.
SmartTRAK is the leading source of competitive intelligence used by the top ten global wound care & orthopedics companies. If you would like a demo of what SmartTRAK has to offer and how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.